Specialty Pharma Journal Specialty, Precision & Technology

WHIPPANY, N.J., Feb. 15, 2019 /PRNewswire/ — Bayer has exercised its option, under a change-in-control clause in the …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced …

NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced …

WHIPPANY, N.J., Feb. 14, 2019 /PRNewswire/ — Results from the pivotal Phase III ARAMIS trial in patients with …

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced data evaluating Opdivo(nivolumab) in combination with Yervoy (ipilimumab) in patients …

VANCOUVER, British Columbia–(BUSINESS WIRE)–AbCellera, a technology leader in therapeutic antibody discovery from natural immune repertoires, …

CAMBRIDGE, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in …

SAN FRANCISCO, Feb. 14, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson …

NOVATO, Calif., TOKYO and LONDON, Feb. 14, 2019 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …

Basel, Switzerland, February 13, 2019 – Novartis announced today that the US Food and Drug Administration (FDA) …

SAN DIEGO, Feb. 13, 2019 /PRNewswire/ — Abilita Bio, Inc. announced today that it has …

New Brunswick, NJ – February 13, 2019 – Focused on creating the next frontier of surgery, Johnson …

BURLINGTON, Ontario and MARKHAM, Ontario, Feb. 12, 2019 /PRNewswire/ — Boehringer Ingelheim (Canada) Ltd. and …

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-4, a Phase 3, …